January 29, 2009 - Medtronic Inc. today reported the expansion of its CURE-AF (Concomitant Utilization of Radiofrequency Energy for Atrial Fibrillation) U.S. clinical program with a post-market study in Europe and Canada.

January 29, 2009 - Boston Scientific Corp. said today it received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its TAXUS Liberte Paclitaxel-Eluting Coronary Stent System.

January 29, 2009 - Medusa Medical Technologies Inc.’s flagship electronic patient care reporting software, the Siren ePCR Suite, now has an interface with the Philips HeartStart MRx monitor/defibrillator.

January 29, 2009 - Epocrates Inc. has introduced its Epocrates Essentials suite for the iPhone and iPod Touch operating systems, which expands upon the company's popular free drug guide to include disease and diagnostic resources.

January 29, 2009 - GE Healthcare's Vascular Ultrasound group and The Medipattern Corp. said they are collaborating on the creation of Ultrasound-based Vascular Imaging Quantification Tools (Vascular iQ).

January 28, 2009 - Philips is leading a major new European project, the SonoDrugs project, which uses focused ultrasound pulses and magnetic resonance imaging (MRI) to deliver and track therapeutic drugs used to treat cancer and cardiovascular disease, in hopes of maximizing efficiency and minimizing side effects.

January 28, 2009 - Australian-based Pro Medicus Limited said today it has acquired Visage Imaging, a digital imaging and advanced 3D visualization technology based in Carlsbad, CA.

January 28, 2009 - Attended by over 40 cardiothoracic surgeons, Cardiogenesis Corp.'s education symposium at the recent Society of Thoracic Surgeons Meeting in San Francisco was entitled "Advancements in Revascularization & Stem Cell Therapy."

January 28, 2009 - Boston Scientific Corp. and Medtronic Inc. today announced the settlement of two lawsuits and an agreement to stand down in three others.

These agreements stop all current litigation between the two parties in the fields of interventional cardiology and endovascular repair. All the disputes involved intellectual property.

January 28, 2009 – Under the terms of a newly penned seven-year agreement, LeMaitre Vascular has earned exclusive rights to market and sell certain sizes of Neovasc Inc.’s biological vascular strip for use in vascular surgery procedures in the U.S. and Europe.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now